首页> 美国卫生研究院文献>Research and Practice in Thrombosis and Haemostasis >Complement factor C4a does not activate protease‐activated receptor 1 (PAR1) or PAR4 on human platelets
【2h】

Complement factor C4a does not activate protease‐activated receptor 1 (PAR1) or PAR4 on human platelets

机译:补体因子C4a不会在人血小板上激活蛋白酶活化受体1(PAR1)或PAR4

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Protease‐activated receptor (PAR) 1 and PAR4 are key thrombin signal mediators for human platelet activation and aggregation in response to vascular injury. They are primarily activated by thrombin cleavage of the N‐terminus to expose a tethered ligand. In addition to the canonical activation by thrombin, a growing panel of proteases can also elicit PAR1‐ or PAR4‐mediated signal transduction. Recently, complement factor C4a was reported as the first endogenous agonist for both PAR1 and PAR4. Further, it is the first endogenous nontethered ligand that activates PAR1 and PAR4. These studies were conducted with human microvascular cells; the impact of C4a on platelet PARs is unknown.
机译:蛋白酶活化受体(par)1和PAR4是用于人类血小板活化和响应血管损伤的聚集的关键凝血酶信号介质。它们主要由N-末端的凝血酶切割激活,以暴露束缚配体。除了凝血酶的规范激活之外,还可以引起PAR1或PAR4介导的信号转导的生长蛋白酶。最近,补码因子C4a被报告为PAR1和PAR4的第一个内源激动剂。此外,它是第一种活化PAR1和PAR4的内源性未培管的配体。这些研究是用人的微血管细胞进行的; C4a对血小板分析的影响是未知的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号